Ben Park
0000-0001-8119-2291
5 papers found
Refreshing results…
Reply to T. Shimoi et al and Y. Shimanuki et al
Updated Results of TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathological Complete Response to Pertuzumab and Trastuzumab in Breast Cancer
Randomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy: ECOG-ACRIN EA1131
TrkA overexpression in non-tumorigenic human breast cell lines confers oncogenic and metastatic properties
The estrogen receptor-alpha S118P variant does not affect breast cancer incidence or response to endocrine therapies
Missing publications? Search for publications with a matching author name.